EP2253633A4 - Kondensierte heterozyklische verbindung - Google Patents

Kondensierte heterozyklische verbindung

Info

Publication number
EP2253633A4
EP2253633A4 EP09719847A EP09719847A EP2253633A4 EP 2253633 A4 EP2253633 A4 EP 2253633A4 EP 09719847 A EP09719847 A EP 09719847A EP 09719847 A EP09719847 A EP 09719847A EP 2253633 A4 EP2253633 A4 EP 2253633A4
Authority
EP
European Patent Office
Prior art keywords
heterocyclic compound
fused heterocyclic
fused
compound
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09719847A
Other languages
English (en)
French (fr)
Other versions
EP2253633A1 (de
Inventor
Tomoyasu Ishikawa
Youichi Kawakita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of EP2253633A1 publication Critical patent/EP2253633A1/de
Publication of EP2253633A4 publication Critical patent/EP2253633A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP09719847A 2008-03-12 2009-03-11 Kondensierte heterozyklische verbindung Withdrawn EP2253633A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008063363 2008-03-12
PCT/JP2009/054603 WO2009113560A1 (ja) 2008-03-12 2009-03-11 縮合複素環化合物

Publications (2)

Publication Number Publication Date
EP2253633A1 EP2253633A1 (de) 2010-11-24
EP2253633A4 true EP2253633A4 (de) 2012-02-29

Family

ID=41063727

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09719847A Withdrawn EP2253633A4 (de) 2008-03-12 2009-03-11 Kondensierte heterozyklische verbindung

Country Status (8)

Country Link
US (1) US20090233937A1 (de)
EP (1) EP2253633A4 (de)
JP (1) JPWO2009113560A1 (de)
AR (1) AR070874A1 (de)
PE (1) PE20091580A1 (de)
TW (1) TW200944528A (de)
UY (1) UY31704A (de)
WO (1) WO2009113560A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20105024B (en) * 2004-06-02 2010-06-25 Takeda Pharmaceuticals Co Fused heterocyclic compound
WO2011040212A1 (en) 2009-10-01 2011-04-07 Takeda Pharmaceutical Company Limited Therapeutic agent for brain tumor
WO2012085244A1 (fr) 2010-12-23 2012-06-28 Sanofi Derives de pyrimidinone, leur preparation et leur utilisation pharmaceutique
KR20130015400A (ko) 2011-08-03 2013-02-14 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함하는 유기 전계 발광 소자
KR101930848B1 (ko) 2011-08-11 2018-12-20 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함하는 유기 전계 발광 소자
KR101971198B1 (ko) 2011-10-19 2019-04-23 삼성디스플레이 주식회사 헤테로시클릭 화합물, 이를 포함하는 유기 발광 소자 및 평판 표시 장치
CA2918242C (en) * 2013-07-31 2022-06-21 Merck Patent Gmbh Pyridines, pyrimidines, and pyrazines, as btk inhibitors and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118588A1 (ja) * 2004-06-02 2005-12-15 Takeda Pharmaceutical Company Limited 縮合複素環化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US6395733B1 (en) * 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
ES2203642T3 (es) 1995-06-07 2004-04-16 Pfizer Inc. Derivados de pirimidina heterociclicos con anillos condensados.
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
TR199900048T2 (xx) 1996-07-13 1999-04-21 Glaxo Group Limited Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler
CA2260767A1 (en) 1996-07-19 1998-01-29 Takeda Chemical Industries, Ltd. Fas ligand-like protein, its production and use
CN1237177A (zh) 1996-11-27 1999-12-01 辉瑞大药厂 稠合的二环嘧啶衍生物
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
WO2001098277A2 (en) 2000-06-22 2001-12-27 Pfizer Products Inc. Substituted bicyclic derivatives for the treatment of abnormal cell growth
CN1211382C (zh) 2000-06-30 2005-07-20 葛兰素集团有限公司 喹唑啉二甲苯磺酸盐化合物
US6984653B2 (en) * 2001-10-05 2006-01-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
WO2003049740A1 (en) 2001-12-12 2003-06-19 Pfizer Products Inc. Quinazoline derivatives for the treatment of abnormal cell growth
NZ532436A (en) 2001-12-12 2006-01-27 Pfizer Prod Inc Salt forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production
EP1463507A1 (de) 2001-12-19 2004-10-06 SmithKline Beecham Corporation Thienopyrimidin-verbindungen als protein-tyrosinkinase-hemmer
TW200730527A (en) * 2005-12-02 2007-08-16 Takeda Pharmaceuticals Co Fused heterocyclic compound
JP4504337B2 (ja) 2006-09-04 2010-07-14 株式会社御池鐵工所 ガス化炉及びガス化炉システム
EP2103620A1 (de) * 2006-12-12 2009-09-23 Takeda Pharmaceutical Company Limited Kondensierte heterocyclische verbindung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118588A1 (ja) * 2004-06-02 2005-12-15 Takeda Pharmaceutical Company Limited 縮合複素環化合物
EP1752457A1 (de) * 2004-06-02 2007-02-14 Takeda Pharmaceutical Company Limited Kondensierte heterocyclische verbindung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009113560A1 *

Also Published As

Publication number Publication date
PE20091580A1 (es) 2009-11-05
EP2253633A1 (de) 2010-11-24
TW200944528A (en) 2009-11-01
WO2009113560A1 (ja) 2009-09-17
JPWO2009113560A1 (ja) 2011-07-21
AR070874A1 (es) 2010-05-12
US20090233937A1 (en) 2009-09-17
UY31704A (es) 2009-11-10

Similar Documents

Publication Publication Date Title
IL289706A (en) A solid containing gamma carbolines fused together with converted heterocycles
ZA201006511B (en) Heterocyclic compound
EP2269990A4 (de) Heterocyclische verbindung
EP2077267A4 (de) Kondensierte heterocyclische verbindung
EP2058309A4 (de) Kondensierte heterocyclische verbindung
EP2334689A4 (de) Kondensierte heterozyklische verbindung
HK1163676A1 (en) Bicyclic heterocyclic compound
IL211933A0 (en) Novel fused aminodihydrothiazine derivative
EP2511269A4 (de) Kondensierte heterocyclische verbindung mit aminogruppe
EP2202223A4 (de) Heterocyclische verbindung
HK1148283A1 (en) Heterocyclic derivatives
EP2173170A4 (de) Annellierte heterozyklen
EP2210876A4 (de) Heterocyclische verbindung
EP2295406A4 (de) Heterocyclische verbindung
EP2399914A4 (de) Fusionierte heterozyklische ringverbindung
EP2314587A4 (de) Nitrogenierte heterocyclische verbindung
HRP20150932T1 (en) Heterocyclic compounds
EP2138482A4 (de) Bicyclische heterocyclische verbindung
EP2253633A4 (de) Kondensierte heterozyklische verbindung
GB0921210D0 (en) Novel heterocyclic derivatives
EP2154139A4 (de) Bicyclische heterocyclische verbindung
GB0919817D0 (en) Heterocyclic compounds
GB0919816D0 (en) Heterocyclic compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100910

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120130

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 487/16 20060101ALI20120124BHEP

Ipc: A61P 43/00 20060101ALI20120124BHEP

Ipc: A61P 35/02 20060101ALI20120124BHEP

Ipc: A61P 35/00 20060101ALI20120124BHEP

Ipc: A61P 31/18 20060101ALI20120124BHEP

Ipc: A61P 31/12 20060101ALI20120124BHEP

Ipc: A61P 9/10 20060101ALI20120124BHEP

Ipc: A61P 9/00 20060101ALI20120124BHEP

Ipc: A61K 31/519 20060101ALI20120124BHEP

Ipc: C07D 487/04 20060101AFI20120124BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120828